Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
3P01CA020432-09S1
Application #
3092885
Study Section
Cancer Therapeutics Program Project Review Committee (CTR)
Project Start
1979-01-01
Project End
1986-06-30
Budget Start
1985-09-30
Budget End
1986-06-30
Support Year
9
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Overall Medical
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Robins, H I; d'Oleire, F; Kutz, M et al. (1995) Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermia. Cancer Lett 89:55-62
Helfand, S C; Soergel, S A; Modiano, J F et al. (1994) Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro. Cancer Biother 9:237-44
Robins, H I; Cohen, J D; Schmitt, C L et al. (1993) Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients. J Clin Oncol 11:1787-94
Cohen, J D; Robins, H I; Katz, T B et al. (1993) Deoxyribonucleoside triphosphate pools and thymidine chemosensitization in human T-cell leukemia. Leuk Res 17:167-74
Storer, B E (1993) Small-sample confidence sets for the MTD in a phase I clinical trial. Biometrics 49:1117-25
Mahvi, D M; Carper, S W; Storm, F K et al. (1993) Overexpression of 27-kDa heat-shock protein in MCF-7 breast cancer cells: effects on lymphocyte-mediated killing by natural killer and gamma delta T cells. Cancer Immunol Immunother 37:181-6
Falkson, G; Tormey, D C; Carey, P et al. (1991) Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer. Eur J Cancer 27:973-7
Jordan, V C (1991) Chemosuppression of breast cancer with long-term tamoxifen therapy. Prev Med 20:3-14
Jordan, V C; Fritz, N F; Langan-Fahey, S et al. (1991) Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst 83:1488-91
Goldstein, D; O'Leary, M; Mitchen, J et al. (1991) Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines. J Urol 146:1173-7

Showing the most recent 10 out of 52 publications